Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2013 Jul 1;63(3):299–306. doi: 10.1097/QAI.0b013e3182945bc7

Table 1.

History of antiretroviral therapy (ART) initiation and continuing ART use and viral suppression at the end of 2010 among patients who received care at a CNICS clinic in 2010 (N=8633)

Percent Percent on Percent
N Ever on Continuing with viral
(% of total) ART ART suppression
Total Population 8633 (100) 94 89 70
Gender1
 Male 7170 (83) 94 90 70
 Female 1372 (16) 92* 86* 66*
 Transgender Women 79 (1) 90 89 62
 Transgender Men 12 (<1) 100 100 75
Age (years)
 18-29 750 (9) 81* 76* 56*
 30-39 1799 (21) 91* 87* 64*
 40-49 3516 (41) 95* 91* 71*
 ≥50 2568 (30) 97 93 77
Race/Ethnicity
 Non-Hispanic White 4222 (49) 94 90 73
 Non-Hispanic Black 2658 (31) 92* 86* 62*
 Hispanic 1243 (14) 95 92 74
 Asian/Pacific Islander 185 (2) 94 91 74
 American Indian 68 (1) 96 90 71
 Multiple/Other 184 (2) 92 89 79
 Missing 73 (1) 92 84 81
HIV Risk Category
 MSM 5365 (62) 94 90* 72*
 IDU (Non-MSM) 820 (10) 94 87 66
 Heterosexual 2131 (25) 93 88 66
 Other 155 (2) 96 88 66
 Missing 162 (2) 95 93 76*
Continuous Care in 2010
 Yes 7237 (84) 94 91 73
 No 1396 (16) 90* 81* 55*

NOTE. Asterisk (*) denotes p<0.05 in Pearson chi-square tests. Reference groups in each category were male gender, ≥50 years of age, Non-Hispanic white race/ethnicity, heterosexual HIV risk category, and engaged in continuous care.